argenx SE (ARGX)
927.21
+32.44
(+3.63%)
USD |
NASDAQ |
Nov 06, 16:00
928.55
+1.34
(+0.14%)
After-Hours: 20:00
argenx Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2014 | -0.0424M |
| Date | Value |
|---|---|
| March 31, 2014 | -0.0014M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 68.03M |
| Cellectis SA | 18.75M |
| Halozyme Therapeutics, Inc. | -62.66M |
| DBV Technologies SA | -5.302M |
| Akari Therapeutics Plc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 1.090B |
| Free Cash Flow Yield | 1.80% |